天富能源所属申万行业为：公用事业-电力-火力发电。所属概念板块包括：太阳能、光伏玻璃、智能电 网、新疆建设兵团、新疆振兴等。 截至9月10日，天富能源股东户数7.40万，较上期增加10.45%；人均流通股18572股，较上期减少 9.46%。2025年1月-6月，天富能源实现营业收入40.66亿元，同比减少10.64%；归母净利润3.04亿元，同 比减少3.00%。 分红方面，天富能源A股上市后累计派现18.12亿元。近三年，累计派现2.93亿元。 9月30日，天富能源盘中上涨2.04%，截至10:01，报9.02元/股，成交2.51亿元，换手率2.06%，总市值 123.97亿元。 资金流向方面，主力资金净流出934.20万元，特大单买入623.40万元，占比2.49%，卖出1382.17万元， 占比5.51%；大单买入4487.48万元，占比17.89%，卖出4662.91万元，占比18.59%。 天富能源今年以来股价涨40.61%，近5个交易日涨4.52%，近20日涨32.45%，近60日涨36.25%。 资料显示，新疆天富能源股份有限公司位于新疆石河子市北一东路2号，成立日期1999年3月28日，上市 ...

9月30日，天康生物盘中下跌2.01%，截至09:51，报7.31元/股，成交5750.80万元，换手率0.57%，总市 值99.80亿元。 截至9月19日，天康生物股东户数6.27万，较上期减少9.64%；人均流通股21770股，较上期增加 10.67%。2025年1月-6月，天康生物实现营业收入88.47亿元，同比增长10.68%；归母净利润3.38亿元， 同比增长22.27%。 分红方面，天康生物A股上市后累计派现18.91亿元。近三年，累计派现5.98亿元。 机构持仓方面，截止2025年6月30日，天康生物十大流通股东中，国泰中证畜牧养殖ETF（159865）位 居第六大流通股东，持股1554.91万股，相比上期增加64.11万股。嘉实农业产业股票A（003634）位居 第九大流通股东，持股1029.45万股，相比上期增加63.01万股。南方中证1000ETF（512100）位居第十 大流通股东，持股1008.39万股，相比上期增加189.78万股。香港中央结算有限公司退出十大流通股东之 列。 责任编辑：小浪快报 资金流向方面，主力资金净流出455.36万元，特大单买入421.53万元，占比7.33% ...

9月29日，天富能源盘中上涨2.01%，截至09:48，报8.62元/股，成交2.09亿元，换手率1.80%，总市值 118.47亿元。 天富能源今年以来股价涨34.37%，近5个交易日跌1.03%，近20日涨30.02%，近60日涨28.85%。 资料显示，新疆天富能源股份有限公司位于新疆石河子市北一东路2号，成立日期1999年3月28日，上市 日期2002年2月28日，公司主营业务涉及电力与热力生产、供应,天然气供应,城镇供水及建筑施工等业 务。主营业务收入构成为：工业80.82%，商业13.58%，施工业4.42%，其他(补充)1.17%。 天富能源所属申万行业为：公用事业-电力-火力发电。所属概念板块包括：太阳能、新疆建设兵团、光 伏玻璃、智能电网、新疆振兴等。 截至9月10日，天富能源股东户数7.40万，较上期增加10.45%；人均流通股18572股，较上期减少 9.46%。2025年1月-6月，天富能源实现营业收入40.66亿元，同比减少10.64%；归母净利润3.04亿元，同 比减少3.00%。 资金流向方面，主力资金净流出497.59万元，特大单买入514.70万元，占比2.47%，卖出993 ...

9月26日，天富能源盘中下跌2.08%，截至13:01，报8.49元/股，成交5.73亿元，换手率4.81%，总市值 116.69亿元。 分红方面，天富能源A股上市后累计派现18.12亿元。近三年，累计派现2.93亿元。 资金流向方面，主力资金净流出2611.25万元，特大单买入3341.14万元，占比5.83%，卖出4293.85万 元，占比7.49%；大单买入1.28亿元，占比22.29%，卖出1.44亿元，占比25.19%。 机构持仓方面，截止2025年6月30日，天富能源十大流通股东中，南方中证1000ETF（512100）位居第 五大流通股东，持股888.32万股，相比上期增加167.26万股。华夏中证1000ETF（159845）位居第八大 流通股东，持股524.05万股，为新进股东。广发中证全指电力ETF（159611）退出十大流通股东之列。 天富能源今年以来股价涨32.35%，近5个交易日跌2.08%，近20日涨28.44%，近60日涨31.22%。 资料显示，新疆天富能源股份有限公司位于新疆石河子市北一东路2号，成立日期1999年3月28日，上市 日期2002年2月28日，公司主营业务涉及电 ...

Core Viewpoint - TianKang Biological has shown a significant increase in stock price and trading volume, indicating positive market sentiment and potential growth in the agricultural and livestock sector [1][2]. Company Overview - TianKang Biological Co., Ltd. is located in Urumqi, Xinjiang, and was established on December 28, 2000, with its stock listed on December 26, 2006. The company specializes in the production and sales of biological vaccines for livestock, feed, and plant protein, as well as pig breeding, pig farming, slaughter processing, and meat product sales [1]. - The revenue composition of TianKang Biological includes: 32.20% from pig farming, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [1]. Financial Performance - For the first half of 2025, TianKang Biological achieved an operating income of 8.847 billion yuan, representing a year-on-year growth of 10.68%. The net profit attributable to the parent company was 338 million yuan, reflecting a year-on-year increase of 22.27% [2]. - Since its A-share listing, TianKang Biological has distributed a total of 1.891 billion yuan in dividends, with 598 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2025, the number of shareholders of TianKang Biological was 69,400, an increase of 1.60% from the previous period. The average number of circulating shares per person decreased by 1.57% to 19,672 shares [2]. - Notable institutional shareholders include Guotai Zhongzheng Livestock Breeding ETF, which holds 15.5491 million shares, and Jiashi Agricultural Industry Stock A, holding 10.2945 million shares, both of which have increased their holdings compared to the previous period [3].

Company Overview - Xinjiang Beixin Road and Bridge Group Co., Ltd. is located in Urumqi, Xinjiang, and was established on August 7, 2001, with its listing date on November 11, 2009 [2] - The company's main business involves construction services for public transportation infrastructure, including highway engineering (91.35%), bridge engineering, tunnel engineering, and municipal traffic engineering [2] - As of June 30, the number of shareholders is 60,600, a decrease of 6.81% from the previous period, with an average of 17,999 circulating shares per person, an increase of 7.30% [2] Financial Performance - For the first half of 2025, the company achieved operating revenue of 4.956 billion yuan, a year-on-year increase of 20.66%, while the net profit attributable to shareholders was -80.91 million yuan, a decrease of 868.68% year-on-year [2] - The company has cumulatively distributed cash dividends of 74.32 million yuan since its A-share listing, with 12.68 million yuan distributed in the last three years [3] Stock Performance - On September 5, the stock price increased by 2.22%, reaching 4.61 yuan per share, with a trading volume of 101 million yuan and a turnover rate of 1.74%, resulting in a total market capitalization of 5.847 billion yuan [1] - Year-to-date, the stock price has risen by 24.59%, with a slight increase of 0.22% over the last five trading days and a 14.96% increase over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on August 14, where the net buying amount was -42.25 million yuan [1]